218 related articles for article (PubMed ID: 23696872)
41. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
Avgeris S; Fostira F; Vagena A; Ninios Y; Delimitsou A; Vodicka R; Vrtel R; Youroukos S; Stravopodis DJ; Vlassi M; Astrinidis A; Yannoukakos D; Voutsinas GE
Sci Rep; 2017 Dec; 7(1):16697. PubMed ID: 29196670
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
43. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.
Feliciano DM; Su T; Lopez J; Platel JC; Bordey A
J Clin Invest; 2011 Apr; 121(4):1596-607. PubMed ID: 21403402
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
Mizuguchi M; Ikeda K; Takashima S
Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093
[TBL] [Abstract][Full Text] [Related]
45. TSC1/TSC2 signaling in the CNS.
Han JM; Sahin M
FEBS Lett; 2011 Apr; 585(7):973-80. PubMed ID: 21329690
[TBL] [Abstract][Full Text] [Related]
46. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
47. Neuropathology of tuberous sclerosis.
Mizuguchi M; Takashima S
Brain Dev; 2001 Nov; 23(7):508-15. PubMed ID: 11701246
[TBL] [Abstract][Full Text] [Related]
48. The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth.
Schrötter S; Yuskaitis CJ; MacArthur MR; Mitchell SJ; Hosios AM; Osipovich M; Torrence ME; Mitchell JR; Hoxhaj G; Sahin M; Manning BD
Cell Rep; 2022 May; 39(7):110824. PubMed ID: 35584673
[TBL] [Abstract][Full Text] [Related]
49. Giant cells: contradiction to two-hit model of tuber formation?
Jozwiak J; Jozwiak S
Cell Mol Neurobiol; 2007 Mar; 27(2):251-61. PubMed ID: 16897363
[TBL] [Abstract][Full Text] [Related]
50. Tuberous sclerosis complex: genetics to pathogenesis.
Narayanan V
Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.
Jones AC; Shyamsundar MM; Thomas MW; Maynard J; Idziaszczyk S; Tomkins S; Sampson JR; Cheadle JP
Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261
[TBL] [Abstract][Full Text] [Related]
52. The genomic landscape of tuberous sclerosis complex.
Martin KR; Zhou W; Bowman MJ; Shih J; Au KS; Dittenhafer-Reed KE; Sisson KA; Koeman J; Weisenberger DJ; Cottingham SL; DeRoos ST; Devinsky O; Winn ME; Cherniack AD; Shen H; Northrup H; Krueger DA; MacKeigan JP
Nat Commun; 2017 Jun; 8():15816. PubMed ID: 28643795
[TBL] [Abstract][Full Text] [Related]
53. Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.
Kútna V; O'Leary VB; Newman E; Hoschl C; Ovsepian SV
Neurotherapeutics; 2021 Apr; 18(2):845-858. PubMed ID: 33398801
[TBL] [Abstract][Full Text] [Related]
54. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.
Yeung RS; Katsetos CD; Klein-Szanto A
Am J Pathol; 1997 Nov; 151(5):1477-86. PubMed ID: 9358774
[TBL] [Abstract][Full Text] [Related]
55. Aberrant beta-catenin signaling in tuberous sclerosis.
Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
[TBL] [Abstract][Full Text] [Related]
56. Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
Woodrum C; Nobil A; Dabora SL
J Transl Med; 2010 Feb; 8():14. PubMed ID: 20146790
[TBL] [Abstract][Full Text] [Related]
57. Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.
Mizuguchi M; Ohsawa M; Kashii H; Sato A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206526
[TBL] [Abstract][Full Text] [Related]
58. Tuberous sclerosis: a syndrome of incomplete tumor suppression.
McCall T; Chin SS; Salzman KL; Fults DW
Neurosurg Focus; 2006 Jan; 20(1):E3. PubMed ID: 16459993
[TBL] [Abstract][Full Text] [Related]
59. Novel TSC1 and TSC2 gene mutations in Chinese patients with tuberous sclerosis complex.
Yu T; He Y; Li N; Zhou Y; Wang Z; Fu Q; Wang J; Wang J
Clin Neurol Neurosurg; 2017 Mar; 154():104-108. PubMed ID: 28178598
[TBL] [Abstract][Full Text] [Related]
60. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
